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New Antitumor Vector
At advanced melanoma stages, 
a very low response rate to 
chemotherapy/radiotherapy 
is observed, underscoring the 
need for immunotherapeutic 
strategies. On the basis of 
reports that induction or 
transfer of functional tumor-
specific effector T cells results 
in melanoma regression, 
Aspord and colleagues 
investigated the potential of 
HLA-A*0201+ plasmacytoid 
dendritic cells (pDCs), which 
function in antitumor immunity, 
for cell-based melanoma 
immunotherapy. Peptide-loaded 
pDCs induced a multispecific 
and highly functional T-cell 
response in patients with 
melanoma. These findings 
provide preclinical evidence 
in support of pDCs as a new 
melanoma immunotherapy 
vector. See page 2395
Copy That
Efforts are under way to 
delineate the contributions of 
genetic factors to psoriasis risk 
after genome-wide association 
studies revealed 20 psoriasis 
susceptibility loci in addition 
to the well-known HLA-Cw6 
(PSORS1) locus. Following the 
report of an association between 
psoriasis and the copy number 
of β-defensin genes in a small 
population from Nijmegen, 
the Netherlands, and Erlangen, 
Germany, Stuart and colleagues 
probed this relationship in 
more than 4,000 psoriasis 
cases and 3,000 controls from 
Erlangen and Michigan. Using 
improved methods of copy 
number–variation measurement, 
these investigators confirmed 
a significant but weak positive 
association between β-defensin 
copy number and psoriasis.  
See page 2407
Hit ’Em with Your Flu Shot
Kaposi’s sarcoma (KS) mainly affects the skin and is con-
sistently associated with human herpesvirus-8 (HHV-8). 
HHV-8 infects a broad range of cell types, including B 
lymphocytes, which are critical in humoral immune con-
trol. Cappelletti and colleagues examined the immuno-
genicity and safety of influenza vaccination in patients 
with classic KS (cKS), who are known to exhibit HHV-
8-driven disrupted B-cell homeostasis. The patients with 
cKS achieved seroprotection similar to that observed 
in healthy controls, demonstrating that these patients 
activate adequate antigen-specific humoral responses. 
Despite an observed vaccination-induced HHV-8 viral 
rebound, the vaccination proved safe in the individuals 
with cKS. Clearly, these patients, who are typically in the high-risk elderly popula-
tion, benefit from seasonal influenza vaccination. See page 2414
Woolly Mutant
In a Japanese family with autosomal-dom-
inant woolly hair (ADWH)/hypotrichosis, 
Fujimoto and colleagues uncovered a het-
erozygous missense mutation (c.422T>G) 
in the fully conserved phenylalanine in the 
helix-initiation motif of the keratin 71 gene 
(KRT71), after excluding mutations in known 
causative genes of nonsyndromic forms of 
WH and AD forms of hypotrichosis via direct sequencing analysis. Furthermore, in 
cultured cells, the resulting mutant K71 disrupted the keratin intermediate filament 
network, suggesting that the mutation is pathogenic for ADWH/hypotrichosis in this 
family. This novel finding will further our understanding of inner root sheath proteins 
in hair follicle development and hair growth. See page 2342
Better to See You With
The public health impact of cutaneous skin 
tumors prompted examination of more 
accurate clinical diagnostic methods. In 
vivo reflectance confocal microscopy (RCM) 
allows visualization of the upper layers of 
the skin at cellular resolution and has been 
shown to improve diagnostic accuracy in 
some cases. Guitera and colleagues ana-
lyzed the RCM characteristics and pathol-
ogy diagnoses of 710 consecutive cutaneous 
lesions in order to develop algorithms for 
accurate diagnosis of basal cell carcinomas 
and melanocytic melanoma. This two-step 
RCM method is a highly accurate noninvasive technique for diagnosis of basal cell 
carcinomas, but accuracy of diagnosis was lower for melanoma. See page 2386
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